DrugPatentWatch Database Preview
Riboflavin 5'-phosphate sodium - Generic Drug Details
» See Plans and Pricing
What are the generic drug sources for riboflavin 5'-phosphate sodium and what is the scope of freedom to operate?
Riboflavin 5'-phosphate sodium
is the generic ingredient in two branded drugs marketed by Avedro Inc and is included in one NDA. Additional information is available in the individual branded drug profile pages.There are ten drug master file entries for riboflavin 5'-phosphate sodium. One supplier is listed for this compound.
Summary for riboflavin 5'-phosphate sodium
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 10 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 36 |
| Patent Applications: | 4,404 |
| DailyMed Link: | riboflavin 5'-phosphate sodium at DailyMed |
Medical Subject Heading (MeSH) Categories for riboflavin 5'-phosphate sodium
US Patents and Regulatory Information for riboflavin 5'-phosphate sodium
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avedro Inc | PHOTREXA | riboflavin 5'-phosphate sodium | SOLUTION/DROPS;OPHTHALMIC | 203324-001 | Apr 15, 2016 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Avedro Inc | PHOTREXA VISCOUS IN DEXTRAN 20% | riboflavin 5'-phosphate sodium | SOLUTION/DROPS;OPHTHALMIC | 203324-002 | Apr 15, 2016 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Avedro Inc | PHOTREXA | riboflavin 5'-phosphate sodium | SOLUTION/DROPS;OPHTHALMIC | 203324-001 | Apr 15, 2016 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Avedro Inc | PHOTREXA VISCOUS IN DEXTRAN 20% | riboflavin 5'-phosphate sodium | SOLUTION/DROPS;OPHTHALMIC | 203324-002 | Apr 15, 2016 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
